Management of Adverse Effects of Endocrine Therapy in Early‐Stage Breast Cancer: Pharmacological and Nonpharmacological Approaches
Clinical Endocrinology · 18.08.2025
DOI: 10.1111/cen.70011 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Endocrinology, online erschienen am 18.08.2025. Verfasst von Timothy B Winslow und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, Department of Medicine & Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Abstract (Originalsprache)
Objective
Over 70% of breast cancers are hormone receptor positive and endocrine therapy (i.e., aromatase inhibitors and tamoxifen) is considered standard of care. Side effects from endocrine therapy can be significant for patients leading to early treatment discontinuation. As adjuvant endocrine therapy is typically recommended for 5–10 years, proactively addressing adverse effects is important to facilitate patient compliance. This review addresses the common adverse effects of adjuvant endocrine therapy in early‐stage breast cancer and approaches to management including both pharmacologic and non‐pharmacologic strategies.
Conclusion
There are multiple pharmacologic and non‐pharmacologic management strategies available to alleviate side effects from endocrine therapy in patients with hormone receptor positive early stage breast cancer. Non‐pharmacologic management strategies may be underutilized and should be considered early in the management of endocrine therapy adverse effects.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology/Oncology, Department of Medicine & Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA.
ORCID-Profile: Timothy B Winslow
Zitieren
APA
Winslow, T. B., Huston, A., O'Regan, R., & Dent, S. (2025). Management of Adverse Effects of Endocrine Therapy in Early‐Stage Breast Cancer: Pharmacological and Nonpharmacological Approaches. Clinical Endocrinology. https://doi.org/10.1111/cen.70011
Vancouver
Winslow TB, Huston A, O'Regan R, Dent S. Management of Adverse Effects of Endocrine Therapy in Early‐Stage Breast Cancer: Pharmacological and Nonpharmacological Approaches. Clinical Endocrinology. 2025. doi:10.1111/cen.70011
BibTeX
@article{Winslow2025,
author = {Winslow, Timothy B and Huston, Alissa and O'Regan, Ruth and Dent, Susan},
title = {Management of Adverse Effects of Endocrine Therapy in Early‐Stage Breast Cancer: Pharmacological and Nonpharmacological Approaches},
journal = {Clinical Endocrinology},
year = {2025},
doi = {10.1111/cen.70011}
}
EUVIMED